Wellcome Trust Sanger Institure – Genome Research Limited

Wellcome Trust Sanger Institute, Genome Research Limited
Genome Research Limited
CB10 1SA
United Kingdom

principal investigator
Tel.: +44 122 349 47 57
Tel.2: +44 122 349 47 39
Michael Stratton (MD, PhD) is Director of the Wellcome Trust Sanger Institute. He was leader of the group that mapped and identified the high risk breast cancer susceptibility gene, BRCA2. His research interests are in the genetics of cancer.